BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2725 related articles for article (PubMed ID: 1672344)

  • 1. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
    J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effects of anti-IL-4 monoclonal antibody on neonatal induction of tolerance and on an associated autoimmune syndrome.
    Schurmans S; Heusser CH; Qin HY; Merino J; Brighouse G; Lambert PH
    J Immunol; 1990 Oct; 145(8):2465-73. PubMed ID: 2212649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies.
    Merino J; Schurmans S; Luzuy S; Izui S; Vassalli P; Lambert PH
    J Immunol; 1987 Sep; 139(5):1426-31. PubMed ID: 3114366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune syndrome after induction of neonatal tolerance to alloantigens. CD4+ T cells from the tolerant host activate autoreactive F1 B cells.
    Merino J; Schurmans S; Duchosal MA; Izui S; Lambert PH
    J Immunol; 1989 Oct; 143(7):2202-8. PubMed ID: 2570803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
    Ramos A; Merino R; Merino J
    Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of Ia antigens on B cells after neonatal induction of lymphoid chimerism in mice: role of interleukin 4.
    Abramowicz D; Doutrelepont JM; Lambert P; Van der Vorst P; Bruyns C; Goldman M
    Eur J Immunol; 1990 Mar; 20(3):469-76. PubMed ID: 2138556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo treatment of neonatal mice with anti-I-A antibodies interferes with the development of the class I, class II, and Mls-reactive proliferating T cell subset.
    Kruisbeek AM; Bridges S; Carmen J; Longo DL; Mond JJ
    J Immunol; 1985 Jun; 134(6):3597-604. PubMed ID: 3157745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Ia treatment prevents lupus-like autoimmune syndrome in mice neonatally tolerized to alloantigens.
    Kramar G; Schurmans S; Aguado T; Izui S; Del Giudice G; Lambert PH
    J Autoimmun; 1993 Feb; 6(1):27-37. PubMed ID: 8096138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal tolerance induction in the thymus to MHC-class-II-associated antigens. V. Thymus medulla and the site for deletional signaling achievement in Mls tolerance.
    Hosono M; Kurozumi M; Ideyama S; Katsura Y
    Thymus; 1992 Aug; 20(1):31-45. PubMed ID: 1387744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of CD8+ cells exacerbates organ-specific autoimmune diseases induced by CD4+ T cells in semiallogeneic hosts with MHC class II disparity.
    Saitoh T; Ikarashi Y; Ito S; Watanabe H; Fujiwara M; Asakura H
    J Immunol; 1990 Nov; 145(10):3268-75. PubMed ID: 2121823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells.
    Herrmann T; Maryanski JL; Romero P; Fleischer B; MacDonald HR
    J Immunol; 1990 Feb; 144(4):1181-6. PubMed ID: 1968075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal tolerance induction by class II alloantigens activates IL-4-secreting, tolerogen-responsive T cells.
    Powell TJ; Streilein JW
    J Immunol; 1990 Feb; 144(3):854-9. PubMed ID: 2136901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of neonatal tolerance to the Mls-1a self-super-antigen. Time kinetics and MHC restriction.
    Dannecker G; Mecheri S; Hoffmann MK
    J Immunol; 1991 Nov; 147(9):2833-8. PubMed ID: 1833458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
    Majlessi L; Bordenave G
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognate interactions between helper T cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells.
    Noelle RJ; McCann J; Marshall L; Bartlett WC
    J Immunol; 1989 Sep; 143(6):1807-14. PubMed ID: 2476483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of host CD4+ T lymphocytes in mice neonatally tolerized to alloantigens.
    Kramar G; Aguado T; Louis J; del Giudice G; Lambert PH
    Eur J Immunol; 1993 Oct; 23(10):2551-6. PubMed ID: 8104795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T cells determine the ability of spleen cells from F1 hybrid mice to induce neonatal tolerance to alloantigens and autoimmunity in parental mice.
    González M; Schurmans S; Ramos A; Merino R; Lambert PH; Merino J
    Eur J Immunol; 1995 Jun; 25(6):1760-4. PubMed ID: 7615004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of anti-donor allohelper T cells after neonatal induction of allotolerance in mice.
    Abramowicz D; Vandervorst P; Bruyns C; Doutrelepont JM; Vandenabeele P; Goldman M
    Eur J Immunol; 1990 Aug; 20(8):1647-53. PubMed ID: 2145162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 137.